<VariationArchive VariationID="1426313" VariationName="NM_178170.3(NEK8):c.882_885del (p.Cys295fs)" VariationType="Deletion" Accession="VCV001426313" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2022-03-28" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1450920" VariationID="1426313">
      <GeneList>
        <Gene Symbol="NEK8" FullName="NIMA related kinase 8" GeneID="284086" HGNC_ID="HGNC:13387" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="28728788" stop="28743455" display_start="28728788" display_stop="28743455" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="27055831" stop="27069783" display_start="27055831" display_stop="27069783" Strand="+" />
          </Location>
          <OMIM>609799</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_178170.3(NEK8):c.882_885del (p.Cys295fs)</Name>
      <CanonicalSPDI>NC_000017.11:28737728:CTGC:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="28737729" stop="28737732" display_start="28737729" display_stop="28737732" variantLength="4" positionVCF="28737728" referenceAlleleVCF="GCTGC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="27064747" stop="27064750" display_start="27064747" display_stop="27064750" variantLength="4" positionVCF="27064746" referenceAlleleVCF="GCTGC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>C295fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.27064747_27064750del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.27064747_27064750del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.28737729_28737732del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.28737729_28737732del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012263.1" sequenceAccession="NG_012263" sequenceVersion="1" change="g.13916_13919del">
            <Expression>NG_012263.1:g.13916_13919del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_178170.3" sequenceAccession="NM_178170" sequenceVersion="3" change="c.882_885del" MANESelect="true">
            <Expression>NM_178170.3:c.882_885del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_835464.1" sequenceAccession="NP_835464" sequenceVersion="1" change="p.Cys295fs">
            <Expression>NP_835464.1:p.Cys295fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2151732872" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_178170.3(NEK8):c.882_885del (p.Cys295fs) AND Nephronophthisis 9" Accession="RCV001931248" Version="3">
        <ClassifiedConditionList TraitSetID="389">
          <ClassifiedCondition DB="MedGen" ID="C3151188">Nephronophthisis 9</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-05" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23418306</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26967905</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="389" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9716" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 9</ElementValue>
                <XRef ID="315147" DB="GeneTests" />
                <XRef ID="MONDO:0013444" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NPHP9</ElementValue>
                <XRef Type="MIM" ID="613824" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-LÃ¸ken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C3151188" DB="MedGen" />
              <XRef ID="MONDO:0013444" DB="MONDO" />
              <XRef Type="MIM" ID="613824" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4224253" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="2892945|MedGen:C3151188" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002201880" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23418306</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26967905</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1426313). This variant has not been reported in the literature in individuals affected with NEK8-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Cys295Glufs*8) in the NEK8 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEK8 are known to be pathogenic (PMID: 23418306, 26967905).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEK8" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.27064747_27064750del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3151188" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4224253" TraitType="Disease" MappingType="XRef" MappingValue="C3151188" MappingRef="MedGen">
        <MedGen CUI="C3151188" Name="Nephronophthisis 9" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

